Search Within

Michael Andrew Postow

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (32)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (81)
  2. Melanoma Disease Management Team (81)
  3. Melanoma and Immunotherapeutics Service (81)
  4. Population Sciences Research Program (81)
  5. Solid Tumor Oncology Division (81)
  6. Epidemiology and Biostatistics (69)

More Groups

People
  1. Katherine Panageas (64)
  2. Jedd Wolchok (48)
  3. Alexander Shoushtari (34)
  4. Margaret Callahan (34)
  5. Paul Chapman (32)
  6. Parisa Momtaz (26)

More People

Years
  1. 2025 (5)
  2. 2024 (8)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. The Oncologist (7)
  3. Annals of Surgical Oncology (5)
  4. Journal for ImmunoTherapy of Cancer (5)
  5. Clinical Cancer Research (4)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Oxford University Press (8)
  3. American Association for Cancer Research (7)
  4. Biomed Central Ltd (5)
  5. Springer (5)
  6. Wiley Blackwell (5)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Associations between race/ethnicity and enrollment in cancer research protocols
    Meeting Abstract

    Ezeoke, O. M.; Brooks, G.; Postow, M. A.; Baxi, S.; Diamond, L.
    Cancer Epidemiology Biomarkers and Prevention (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma
    Journal Article

    Shoushtari, A. N.; Friedman, C. F.; Navid-Azarbaijani, P.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Panageas, K. S.; Wolchok, J. D.; Chapman, P. B.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Sequential, multiple assignment, randomized trial designs in immuno-oncology research
    Journal Article

    Kidwell, K. M.; Postow, M. A.; Panageas, K. S.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical and immunologic variables associated with outcomes following combination ipilimumab and nivolumab immunotherapy in melanoma
    Meeting Abstract

    Rosner, S.; Kwong, E.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Patient perspectives on ipilimumab across the melanoma treatment trajectory
    Journal Article

    Shuk, E.; Shoushtari, A. N.; Luke, J.; Postow, M. A.; Callahan, M.; Harding, J. J.; Roth, K. G.; Flavin, M.; Granobles, A.; Christian, J.; more...
    Supportive Care in Cancer (2017)

    Fulltext@MSK | Save
  • Elevated blood neutrophil-to-lymphocyte ratio: A readily available biomarker associated with death due to disease in high risk nonmetastatic melanoma
    Journal Article

    Davis, J. L.; Langan, R. C.; Panageas, K. S.; Zheng, J.; Postow, M. A.; Brady, M. S.; Ariyan, C.; Coit, D. G.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save